252 related articles for article (PubMed ID: 6196296)
1. Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing.
Pluschke G; Mayden J; Achtman M; Levine RP
Infect Immun; 1983 Dec; 42(3):907-13. PubMed ID: 6196296
[TBL] [Abstract][Full Text] [Related]
2. Degree of antibody-independent activation of the classical complement pathway by K1 Escherichia coli differs with O antigen type and correlates with virulence of meningitis in newborns.
Pluschke G; Achtman M
Infect Immun; 1984 Feb; 43(2):684-92. PubMed ID: 6198283
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to O-antigen of lipopolysaccharide are protective against neonatal infection with Escherichia coli K1.
Pluschke G; Achtman M
Infect Immun; 1985 Aug; 49(2):365-70. PubMed ID: 2410365
[TBL] [Abstract][Full Text] [Related]
4. K1, K5 and O antigens of Escherichia coli in relation to serum killing via the classical and alternative complement pathways.
Devine DA; Roberts AP
J Med Microbiol; 1994 Aug; 41(2):139-44. PubMed ID: 7519270
[TBL] [Abstract][Full Text] [Related]
5. Induction of bacteremia in newborn rats by Escherichia coli K1 is correlated with only certain O (lipopolysaccharide) antigen types.
Pluschke G; Mercer A; Kusećek B; Pohl A; Achtman M
Infect Immun; 1983 Feb; 39(2):599-608. PubMed ID: 6187683
[TBL] [Abstract][Full Text] [Related]
6. A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli.
Schiffer MS; Oliveira E; Glode MP; McCracken GH; Sarff LM; Robbins JB
Pediatr Res; 1976 Feb; 10(2):82-7. PubMed ID: 1107953
[TBL] [Abstract][Full Text] [Related]
7. Use of a bacteriophage-encoded glycanase enzyme in the generation of lipopolysaccharide O side chain deficient mutants of Escherichia coli O9:K30 and Klebsiella O1:K20: role of O and K antigens in resistance to complement-mediated serum killing.
McCallum KL; Laakso DH; Whitfield C
Can J Microbiol; 1989 Nov; 35(11):994-9. PubMed ID: 2482125
[TBL] [Abstract][Full Text] [Related]
8. Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis.
Bortolussi R; Ferrieri P; Björkstén B; Quie PG
Infect Immun; 1979 Jul; 25(1):293-8. PubMed ID: 383617
[TBL] [Abstract][Full Text] [Related]
9. The mechanisms of activation of normal human serum complement by Escherichia coli strains with K1 surface antigen.
Bugla-Płoskońska G; Cisowska A; Karpińska K; Jankowski S; Doroszkiewicz W
Folia Microbiol (Praha); 2006; 51(6):627-32. PubMed ID: 17455802
[TBL] [Abstract][Full Text] [Related]
10. The association of the O18, K1 and H7 antigens and the Co1V plasmid of a strain of Escherichia coli with its virulence and immunogenicity.
Smith HW; Huggins MB
J Gen Microbiol; 1980 Dec; 121(2):387-400. PubMed ID: 7021764
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide.
Joiner KA; Schmetz MA; Goldman RC; Leive L; Frank MM
Infect Immun; 1984 Jul; 45(1):113-7. PubMed ID: 6203836
[TBL] [Abstract][Full Text] [Related]
12. Influence of growth temperature of Escherichia coli on K1 capsular antigen production and resistance to opsonization.
Bortolussi R; Ferrieri P; Quie PG
Infect Immun; 1983 Mar; 39(3):1136-41. PubMed ID: 6341228
[TBL] [Abstract][Full Text] [Related]
13. A New Tool for Complement Research:
Mutti M; Ramoni K; Nagy G; Nagy E; Szijártó V
Front Immunol; 2018; 9():2770. PubMed ID: 30564230
[TBL] [Abstract][Full Text] [Related]
14. Escherichia coli in bacteremia: O-acetylated K1 strains appear to be more virulent than non-O-acetylated K1 strains.
Frasa H; Procee J; Torensma R; Verbruggen A; Algra A; Rozenberg-Arska M; Kraaijeveld K; Verhoef J
J Clin Microbiol; 1993 Dec; 31(12):3174-8. PubMed ID: 7508454
[TBL] [Abstract][Full Text] [Related]
15. Virulence factors of Escherichia coli. III. Correlation with Escherichia coli pathogenicity of haemolysin production, haemagglutinating capacity, antigens K1, K5, and colicinogenicity.
Czirók E; Milch H; Csiszár K; Csik M
Acta Microbiol Hung; 1986; 33(1):69-83. PubMed ID: 3529796
[TBL] [Abstract][Full Text] [Related]
16. Relative contribution of ColV plasmid and K1 antigen to the pathogenicity of Escherichia coli.
Agüero ME; Cabello FC
Infect Immun; 1983 Apr; 40(1):359-68. PubMed ID: 6339405
[TBL] [Abstract][Full Text] [Related]
17. Role of lipopolysaccharide and capsule in the serum resistance of bacteremic strains of Escherichia coli.
Cross AS; Kim KS; Wright DC; Sadoff JC; Gemski P
J Infect Dis; 1986 Sep; 154(3):497-503. PubMed ID: 3525697
[TBL] [Abstract][Full Text] [Related]
18. Acquisition of genes from an O18:K1:H7 ColV+ strain of Escherichia coli renders intracranially-inoculated E. coli K12 highly virulent for chickens, ducks and guinea-pigs but not mice.
Smith HW; Huggins MB
J Hyg (Lond); 1985 Oct; 95(2):363-74. PubMed ID: 3905956
[TBL] [Abstract][Full Text] [Related]
19. Preclinical validation of an
Chorro L; Ndreu D; Patel A; Kodali S; Li Z; Keeney D; Dutta K; Sasmal A; Illenberger A; Torres CL; Pan R; Silmon de Monerri NC; Chu L; Simon R; Anderson AS; Donald RGK
Microbiol Spectr; 2024 Jun; 12(6):e0421323. PubMed ID: 38700324
[TBL] [Abstract][Full Text] [Related]
20. The sensitivity of escherichia coli strains with K1 surface antigen and rods without this antigen to the bactericidal effect of serum.
Cisowska A; Jankowski S
Folia Microbiol (Praha); 2004; 49(4):471-8. PubMed ID: 15530015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
